News
Researchers have found in a new study that compared to traditional open sinus surgery, nasal endoscopy offers a safer and ...
Nasal endoscopic surgery for chronic sinusitis with nasal polyps results in shorter operative time, reduced intraoperative blood loss, and fewer postoperative complications compared to traditional ...
TUESDAY, May 6, 2025 (HealthDay News) -- For patients with chronic sinusitis and nasal polyps, nasal endoscopic surgery can remove polyps in a shorter time, with less intraoperative blood loss ...
National Institutes of Health grant will fund randomized clinical trial for treatments Timothy Smith, M.D., M.P.H., professor ...
The second indication is as an add-on maintenance treatment of adult patients with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP). The NDS is based on data from the ...
Market Overview: The Global Nasal Polyposis Drugs Market is expanding rapidly, owing to advances in biologic medicines, minimally invasive surgical procedures, and personalized medicine approaches.
CRSwNP recurrence after surgery is linked to high eosinophils, GERD, diabetes, and asthma. A new model accurately predicts ...
The second indication is as an add-on maintenance treatment of adult patients with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP). The NDS is based on data from the positive ...
Regeneron and SNY's itepekimab meets the primary endpoint in one COPD trial but misses in another, leaving future plans under review.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi SA (NASDAQ:SNY) on Friday announced results from two Phase 3 trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results